Frederic Moll H.'s most recent trade in Procept BioRobotics Corp was a trade of 26,749 Common Stock done at an average price of $1.3 . Disclosure was reported to the exchange on Feb. 10, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Procept BioRobotics Corp | Frederic H. Moll | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.33 per share. | 10 Feb 2025 | 26,749 | 836,358 | - | 1.3 | 35,576 | Common Stock |
Procept BioRobotics Corp | Frederic H. Moll | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 26,749 | 0 | - | - | Stock Option (Right to Buy) | |
Procept BioRobotics Corp | Frederic H. Moll | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.86 per share. | 10 Feb 2025 | 5,263 | 841,621 | - | 0.9 | 4,526 | Common Stock |
Procept BioRobotics Corp | Frederic H. Moll | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 5,263 | 0 | - | - | Stock Option (Right to Buy) | |
Procept BioRobotics Corp | Frederic H. Moll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 2,526 | 2,526 | - | - | Stock Option (Right to Buy) | |
Procept BioRobotics Corp | Frederic H. Moll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 1,376 | 809,609 | - | 0 | Common Stock | |
ShockWave Medical Inc | Frederic H. Moll | Director | Sale of securities on an exchange or to another person at price $ 255.95 per share. | 21 Feb 2024 | 16,464 | 324,613 (1%) | 0% | 256.0 | 4,213,961 | Common Stock |
ShockWave Medical Inc | Frederic H. Moll | Director | Sale of securities on an exchange or to another person at price $ 256.82 per share. | 21 Feb 2024 | 14,165 | 310,448 (1%) | 0% | 256.8 | 3,637,855 | Common Stock |
ShockWave Medical Inc | Frederic H. Moll | Director | Sale of securities on an exchange or to another person at price $ 258.09 per share. | 21 Feb 2024 | 8,649 | 301,799 (1%) | 0% | 258.1 | 2,232,220 | Common Stock |
ShockWave Medical Inc | H. Moll Frederic | Director | Sale of securities on an exchange or to another person at price $ 255.14 per share. | 21 Feb 2024 | 6,444 | 341,077 (1%) | 0% | 255.1 | 1,644,122 | Common Stock |
ShockWave Medical Inc | Frederic Moll H. | Director | Sale of securities on an exchange or to another person at price $ 259.91 per share. | 21 Feb 2024 | 5,528 | 293,611 (1%) | 0% | 259.9 | 1,436,782 | Common Stock |
ShockWave Medical Inc | Moll H. Frederic | Director | Sale of securities on an exchange or to another person at price $ 260.80 per share. | 21 Feb 2024 | 4,890 | 288,721 (1%) | 0% | 260.8 | 1,275,312 | Common Stock |
ShockWave Medical Inc | Frederic Moll H. | Director | Sale of securities on an exchange or to another person at price $ 258.95 per share. | 21 Feb 2024 | 2,660 | 299,139 (1%) | 0% | 259.0 | 688,807 | Common Stock |
ShockWave Medical Inc | Moll Frederic H. | Director | Sale of securities on an exchange or to another person at price $ 261.96 per share. | 21 Feb 2024 | 1,200 | 287,521 (1%) | 0% | 262.0 | 314,352 | Common Stock |
ShockWave Medical Inc | Moll Frederic H. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 08 Feb 2024 | 81,967 | 347,521 (1%) | 0% | 0.6 | 50,000 | Common Stock |
ShockWave Medical Inc | Moll H. Frederic | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 81,967 | 0 | - | - | Stock Option | |
Procept BioRobotics Corp | Frederic H. Moll | Director | Sale of securities on an exchange or to another person at price $ 38.49 per share. | 06 Dec 2023 | 51,758 | 835,475 | - | 38.5 | 1,992,196 | Common Stock |
Procept BioRobotics Corp | Moll Frederic H. | Director | Sale of securities on an exchange or to another person at price $ 39.25 per share. | 06 Dec 2023 | 27,242 | 808,233 | - | 39.2 | 1,069,159 | Common Stock |
Procept BioRobotics Corp | Frederic H. Moll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 4,865 | 4,865 | - | - | Stock Option (Right to Buy) | |
Procept BioRobotics Corp | Frederic H. Moll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 2,711 | 887,233 | - | 0 | Common Stock | |
ShockWave Medical Inc | Frederic H. Moll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 736 | 231,594 (0%) | 0% | 0 | Common Stock | |
ShockWave Medical Inc | Frederic H. Moll | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 33,960 | 230,858 (0%) | 0% | 0 | Common Stock | |
ShockWave Medical Inc | Frederic H. Moll | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 9,300 | 264,818 (0%) | 0% | 0 | Common Stock | |
ShockWave Medical Inc | Frederic H. Moll | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 9,300 | 283,418 (1%) | 0% | 0 | Common Stock | |
ShockWave Medical Inc | Frederic H. Moll | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 9,300 | 274,118 (0%) | 0% | 0 | Common Stock | |
ShockWave Medical Inc | Frederic H. Moll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 994 | 292,718 (1%) | 0% | 0 | Common Stock | |
Procept BioRobotics Corp | Frederic H. Moll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 4,205 | 4,205 | - | - | Common Stock | |
Procept BioRobotics Corp | Frederic H. Moll | Director | Grant, award, or other acquisition of securities at price $ 37.48 per share. | 07 Jun 2022 | 2,001 | 884,522 | - | 37.5 | 74,997 | Common Stock |
ShockWave Medical Inc | Frederic H. Moll | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.49 per share. | 30 Nov 2021 | 12,295 | 291,724 (1%) | 0% | 0.5 | 6,000 | Common Stock |
ShockWave Medical Inc | Frederic H. Moll | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2021 | 12,295 | 0 | - | - | Stock Option | |
Procept BioRobotics Corp | Frederic H. Moll | Director | Purchase of securities on an exchange or from another person at price $ 25.00 per share. | 17 Sep 2021 | 400,000 | 882,521 | - | 25 | 10,000,000 | Common Stock |
Procept BioRobotics Corp | Frederic H. Moll | Director | 17 Sep 2021 | 329,890 | 482,521 | - | - | Common Stock | ||
Procept BioRobotics Corp | Frederic H. Moll | Director | 17 Sep 2021 | 108,214 | 0 | - | - | Series D Convertible Preferred Stock | ||
Procept BioRobotics Corp | Frederic H. Moll | Director | 17 Sep 2021 | 89,840 | 0 | - | - | Series C Convertible Preferred Stock | ||
Procept BioRobotics Corp | Frederic H. Moll | Director | 17 Sep 2021 | 60,172 | 0 | - | - | Series G Convertible Preferred Stock | ||
Procept BioRobotics Corp | Frederic H. Moll | Director | 17 Sep 2021 | 45,586 | 0 | - | - | Series B Convertible Preferred Stock | ||
Procept BioRobotics Corp | Frederic H. Moll | Director | 17 Sep 2021 | 16,974 | 0 | - | - | Series F Convertible Preferred Stock | ||
Procept BioRobotics Corp | Frederic H. Moll | Director | 17 Sep 2021 | 9,104 | 0 | - | - | Series E Convertible Preferred Stock | ||
ShockWave Medical Inc | Frederic H. Moll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2021 | 850 | 279,429 (0%) | 0% | 0 | Common Stock | |
ShockWave Medical Inc | Frederic H. Moll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2020 | 2,701 | 278,579 (0%) | 0% | 0 | Common Stock |